Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1998 Jan 15;101(2):497-502.
doi: 10.1172/JCI1101.

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients

S A Spector  1 , R Wong, K Hsia, M Pilcher, M J Stempien
Affiliations
Clinical Trial

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients

S A Spector et al. J Clin Invest. .

Abstract

In this study, baseline plasma from 619 persons with acquired immunodeficiency syndrome (AIDS) (median CD4+ lymphocyte count -21/microl) who participated in a trial to determine the efficacy of oral ganciclovir for cytomegalovirus (CMV) disease prevention were evaluated for CMV DNA load by qualitative and quantitative polymerase chain reaction (PCR), and correlated with the development of CMV disease and survival. For participants without detectable plasma CMV DNA, the 12-mo Kaplan-Meier CMV disease event rate was 14% and 1% for the placebo and ganciclovir groups, respectively (P < 0.001). For PCR positive participants, CMV disease developed in 43% of placebo and 26% ganciclovir recipients (P < 0.017). Among placebo recipients, CMV PCR positivity was associated with a 3.4-fold increased risk of developing CMV disease (P < 0.001) whereas CD4+ lymphocyte count was not a useful predictor (P = 0.47). A positive plasma CMV DNA PCR was also associated with a 2.5-fold increased risk of death. Each log10 increase in baseline CMV DNA load was associated with a 3.1-fold increase in CMV disease (P < 0.001) and a 2.2-fold increase in mortality (P < 0.001). These data indicate that the risk of developing CMV disease and death in persons with advanced AIDS is directly related to the quantity of CMV DNA in plasma, and is a better predictor than CD4+ lymphocyte count in this population.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ann Intern Med. 1988 Dec 15;109(12):963-9 - PubMed
    1. J Clin Microbiol. 1990 Mar;28(3):495-503 - PubMed
    1. Rev Infect Dis. 1990 Sep-Oct;12 Suppl 7:S820-6 - PubMed
    1. Ann Intern Med. 1991 Nov 1;115(9):665-73 - PubMed
    1. Clin Infect Dis. 1992 Feb;14(2):608-15 - PubMed

Publication types

MeSH terms